Cleary Gottlieb Reps Alkermes In $960M Elan Unit Buy
Under the terms of the cash-and-stock transaction, Waltham, Mass.-based Alkermes will merge with Elan Drug Technologies under a new holding company, Alkermes PLC, to be headquartered in Elan's home base of Dublin.
The merger with EDT will increase Alkermes' focus on developing treatments for central nervous system diseases...
Already a subscriber? Click here to login